Nanoparticles of metal-organic cages designed to encapsulate platinum-based anticancer agents.
Dalton Trans
; 47(3): 670-674, 2018 Jan 15.
Article
in En
| MEDLINE
| ID: mdl-29257160
We present a novel design to use metal-organic cages (MOCs) to encapsulate Pt-based anticancer agents for delivery. A fluorescein-conjugated Pt(iv) prodrug of cisplatin is developed for its encapsulation in a cationic MOC via host-guest interactions, which then forms drug-loaded nanoparticles with an anionic polymer.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organometallic Compounds
/
Drug Carriers
/
Cisplatin
/
Nanoparticles
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Dalton Trans
Journal subject:
QUIMICA
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom